top of page

CHO-K1/Human CysLT2 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0126A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The cysteinyl leukotriene receptor 2 (CYSLT2) is a G protein-coupled receptor mediating the effects of cysteinyl leukotrienes (e.g., LTC4, LTD4). It is primarily distributed in pulmonary vasculature and airway smooth muscle, heart, brain, kidneys, and various immune cells. Its core function, via Gq protein signaling, is to mediate bronchoconstriction, increased vascular permeability, mucus secretion, and fibrotic responses, playing a pivotal role in pathological processes such as asthma, allergic diseases, and ischemia-reperfusion injury. Together with CYSLT1, it constitutes a major effector pathway for leukotriene signaling and is an important therapeutic target for inflammatory diseases like asthma.

 

Screeningbio’s CHO-K1/Human CysLT2 cell line overexpress CYSLTR2 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

CYSLTR2

Accession Number

SNB-G-0126A

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Human CysLT2 Agonist Assay. CHO-K1/Human CysLT2 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human CysLT2 Agonist Assay. CHO-K1/Human CysLT2 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


The cysteinyl leukotriene receptor 2 (CYSLT2) is a G protein-coupled receptor mediating the effects of cysteinyl leukotrienes (e.g., LTC4, LTD4). It is primarily distributed in pulmonary vasculature and airway smooth muscle, heart, brain, kidneys, and various immune cells.


Its core function, via Gq protein signaling, is to mediate bronchoconstriction, increased vascular permeability, mucus secretion, and fibrotic responses, playing a pivotal role in pathological processes such as asthma, allergic diseases, and ischemia-reperfusion injury.


Together with CYSLT1, it constitutes a major effector pathway for leukotriene signaling and is an important therapeutic target for inflammatory diseases like asthma.

Product Documentation



bottom of page